Inventor · disambiguated record
Iqbal Grewal
Also filed as: GREWAL IQBAL · GREWAL IQBAL S
19 granted patents·37 pending applications·128 citations·filing 2000–2025
91Inventor score
Top patents by PatentIndex Score
56 records- 0194US8980267B2Engineered antibody-interferon mutant fusion moleculesIMMUNGENE INC·Filed 2013·Granted Mar 17, 2015·69 cites·24 claims
- 0291US11667712B2Materials and methods for modulating t cell mediated immunityJANSSEN BIOTECH INC·Filed 2020·Granted Jun 6, 2023·2 cites·41 claims
- 0391US9534056B2Engineered TAA antibody-TNFSF member ligand fusion moleculesGREWAL IQBAL·Filed 2012·Granted Jan 3, 2017·37 cites·9 claims
- 0489US11981932B2Materials and methods for the manufacture of pluripotent stem cellsJANSSEN BIOTECH INC·Filed 2021·Granted May 14, 2024·1 cites·12 claims
- 0583US9783589B2Engineered antibody-interferon fusion molecules for treatment of autoimmune diseasesIMMUNGENE INC·Filed 2013·Granted Oct 10, 2017·5 cites·9 claims
- 0683US7393532B1Modulation of T cell differentiation for the treatment of T helper cell mediated diseasesGENENTECH INC·Filed 2000·Granted Jul 1, 2008·13 cites·9 claims
- 0781US12129310B2Materials and methods for enhanced linker targetingJANSSEN BIOTECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·16 claims
- 0879US12492256B2Methods and compositions for modulating beta chain mediated immunityJANSSEN BIOTECH INC·Filed 2024·Granted Dec 9, 2025·0 cites·28 claims
- 0979US2023250171A1Materials And Methods For Binding Siglec-3/CD33JANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1079US2023365684A1Materials And Methods For Binding Siglec-3/CD33JANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1179US2023365683A1Materials And Methods For Binding Siglec-3/CD33JANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1278US2024360421A1Materials and methods for the manufacture of pluripotent stem cellsJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1375US2025043004A1Multi-specific immune targeting molecules and uses thereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1475US2024424130A1Compositions and methods for modulating delta gamma chain mediated immunityJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1573US11639396B2Antibody binding to a linker peptideJANSSEN BIOTECH INC·Filed 2022·Granted May 2, 2023·0 cites·15 claims
- 1672US2024150464A1Materials and methods for modulating t cell mediated immunityJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 1770US11965024B2Methods and compositions for modulating beta chain mediated immunityJANSSEN BIOTECH INC·Filed 2021·Granted Apr 23, 2024·0 cites·34 claims
- 1869US2024293453A1Materials and methods for binding siglec-3/cd33JANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1968US9534057B2Methods of treating tumors with engineered antibody-interferon mutant fusion moleculesIMMUNGENE INC·Filed 2015·Granted Jan 3, 2017·1 cites·10 claims
- 2067US2022267456A1Materials and methods for targeting regulatory t cells for enhancing immune surveillanceJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2166US2025326852A1Materials and methods for targeting regulatory t cells for enhancing immune surveillanceJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites
- 2265US12076413B2Compositions and methods for modulating delta gamma chain mediated immunityJANSSEN BIOTECH INC·Filed 2021·Granted Sep 3, 2024·0 cites·13 claims
- 2364US12264197B2Anti-Vβ17/anti-CD123 bispecific antibodiesJANSSEN BIOTECH INC·Filed 2020·Granted Apr 1, 2025·0 cites·25 claims
- 2464US2025205280A1Methods and Compositions Comprising V beta 17 Bispecific T Cell Engagers and Bioengineered Virus Specific LymphocytesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2564US2011097325A1Modulation of T cell Differentiation for the treatment of T helper cell mediated diseasesGENENTECH INC·Filed 2009·Application pending·0 cites
- 2663US2022089737A1Multi-specific immune targeting molecules and uses thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 2763US2021284730A1Materials and methods for modulating delta chain mediated immunityJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 2862US2025257132A1ANTI-Vbeta17/ANTI-CD123 BISPECIFIC ANTIBODIESJANSSEN BIOTECH INC·Filed 2025·Application pending·0 cites
- 2960US2007178091A1Combination TherapyGENENTECH INC·Filed 2006·Application pending·0 cites
- 3058US12492226B2Materials and methods for producing bioengineered virus specific lymphocytesJANSSEN BIOTECH INC·Filed 2021·Granted Dec 9, 2025·0 cites·14 claims
- 3158US12448449B2Immune targeting molecules and uses thereofJANSSEN BIOTECH INC·Filed 2021·Granted Oct 21, 2025·0 cites·5 claims
- 3258US2009311255A1Preventing autoimmune diseaseGENENTECH INC·Filed 2009·Application pending·0 cites
- 3358US2021355442A1Gamma delta t cells and uses thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 3457US2017233482A1Combination therapyGENENTECH INC·Filed 2016·Application pending·0 cites
- 3557US2007134238A1Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated DiseasesGENENTECH INC·Filed 2006·Application pending·0 cites
- 3656US11926667B2Bioengineered T cell mediated immunity, materials and other methods for modulating cluster of differentiation IV and/or VIIIJANSSEN BIOTECH INC·Filed 2021·Granted Mar 12, 2024·0 cites·21 claims
- 3756US10259854B2Engineered antibody-interferon mutant fusion moleculesIMMUNGENE INC·Filed 2016·Granted Apr 16, 2019·0 cites·12 claims
- 3856US2021214440A1Materials and methods for in vivo biological targetingJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 3955US2021284731A1Methods and materials for modulating an immune responseJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 4055US2024010991A1Materials and methods for bioengineered ipsc populationsJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 4155US2011123531A1Combination therapyGENENTECH INC·Filed 2011·Application pending·0 cites
- 4255US2022306739A1Materials and methods for modulating an immune responseJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 4355US2020268797A1Gamma delta t cells and uses thereofJANSSEN BIOTECH INC·Filed 2019·Application pending·0 cites
- 4454US2009017014A1Compositions and methods for the treatment of immune related diseasesVALDEZ PATRICIA A·Filed 2008·Application pending·0 cites
- 4553US12275766B2Neoantigen peptide mimicsJANSSEN BIOTECH INC·Filed 2021·Granted Apr 15, 2025·0 cites·14 claims
- 4652US2002197256A1Combination therapyGENENTECH INC·Filed 2002·Application pending·0 cites
- 4752US2004234522A1Type I cytokine receptor TCCRGENENTECH INC·Filed 2003·Application pending·0 cites
- 4850US2005043516A1TACI antibodies and uses thereofGENENTECH INC·Filed 2003·Application pending·0 cites
- 4949US7419799B2Compositions and methods for the treatment of immune related diseasesGENENTECH INC·Filed 2002·Granted Sep 2, 2008·0 cites·6 claims
- 5049US2008171036A1Taci antibodies and uses thereofCHUNTHARAPAI ANAN·Filed 2007·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Iqbal Grewal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →